Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, View ORCID ProfileMcKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, View ORCID ProfileDenis Nash
doi: https://doi.org/10.1101/2022.04.23.22274214
Saba A Qasmieh
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
McKaylee M Robertson
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
Chloe A Teasdale
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
Sarah G Kulkarni
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
Denis Nash
1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); 55 W 125th St, 6th Floor, New York, NY 10027, USA
2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); 55 W 125th St, New York, NY 10027, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted April 27, 2022.
Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Denis Nash
medRxiv 2022.04.23.22274214; doi: https://doi.org/10.1101/2022.04.23.22274214
Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022
Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Denis Nash
medRxiv 2022.04.23.22274214; doi: https://doi.org/10.1101/2022.04.23.22274214
Subject Area
Subject Areas
- Addiction Medicine (331)
- Allergy and Immunology (655)
- Anesthesia (175)
- Cardiovascular Medicine (2544)
- Dermatology (213)
- Emergency Medicine (387)
- Epidemiology (12025)
- Forensic Medicine (10)
- Gastroenterology (724)
- Genetic and Genomic Medicine (3942)
- Geriatric Medicine (371)
- Health Economics (660)
- Health Informatics (2546)
- Health Policy (981)
- Hematology (354)
- HIV/AIDS (816)
- Medical Education (391)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3704)
- Nursing (205)
- Nutrition (551)
- Oncology (1927)
- Ophthalmology (560)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (245)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1081)
- Primary Care Research (438)
- Public and Global Health (6374)
- Radiology and Imaging (1345)
- Respiratory Medicine (850)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (184)
- Urology (159)